![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » Ortho Clinical Gains CE Mark for Cardiac Assay
Ortho Clinical Gains CE Mark for Cardiac Assay
July 24, 2019
Ortho Clinical Diagnostics has received the CE Mark for an improved version of its Vitros NT-proBNP II product, a diagnostic used to identify heart failure.
The assay is also designed for risk stratification — grouping patients based on their risk and rising risk — of acute coronary syndrome and heart failure.
The enhanced version of the assay has improved assay quality through the use of monoclonal antibodies and an enhanced resistance to potential interferences.
Upcoming Events
-
21Oct